Internet-based Exposure Therapy for Panic Disorder
- Conditions
- Panic Disorder With Agoraphobia
- Registration Number
- NCT03061448
- Lead Sponsor
- Karolinska Institutet
- Brief Summary
The purpose of this study is examine if an internet-based exposure therapy based on inhibitory learning is feasible, acceptable and effective in reducing panic symptoms amongst patients who suffer from panic disorder and agoraphobia.
- Detailed Description
Trial objectives: Primary objective is to examine if an internet-based exposure therapy based on inhibitory learning is effective in reducing panic symptoms. The secondary objective is to study if the protocol is feasible and acceptable. Secondary objective is measured is examined on 1) number of participants completing the study protocol, 2) participants' satisfaction with the treatment, 3) therapists' ratings of acceptability. The aim of this study is to assess the feasibility, and pilot the design and delivery of a RCT that will subsequently form the framework for a larger RCT to evaluate the effectiveness of an exposure protocol based on inhibitory learning.
Trial Design: Randomized controlled pilot study with two groups randomly assigned to either Internet-based exposure therapy based on the principles of inhibitory learning or Internet-based exposure therapy based on the principles of habituation Duration: Eight weeks Primary Endpoint: Change in panic symptoms from baseline to Week 8. Efficacy Parameters: Panic Disorder Severity Scale - Self rated (PDSS-SR) Safety Parameters: Adverse Events is assessed weekly via the internet. Description of Trial Subjects: Patients \> 18 years old with a PDSS-SR score more than 6 points Number of Subjects: 80
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 61
- Outpatients
- ≥ 18 years
- Situated in Sweden
- Informed consent
- Panic Disorder Severity Scale - self rated score more than 6 points
- Substance dependence during the last six months
- Post traumatic stress disorder, bipolar disorder or psychosis
- Symptoms better explained by axis 2 diagnosis (e.g. autism or borderline personality disorder)
- MADRS-S score above 25 points
- Psychotropic medication changes within one months prior to treatment that could affect target symptoms.
- Received exposure based Cognitive behavior therapy (CBT) for pathological worry the last 2 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Panic Disorder Severity Scale - Self rated (PDSS-SR) Week 0, Week 8 Change in panic symptoms from baseline to Week 8
- Secondary Outcome Measures
Name Time Method Client Satisfaction Questionnaire (CSQ) Week 8 To assess client satisfaction with treatment
Anxiety Sensitivity Index (ASI) Week 0, Week 8 Change in fear of anxiety-related physical sensations
Patient Health Questionnaire (PHQ-9) Week 0, Week 8 Change in depression from baseline to Week 8
HA-NI-SSD Symptom Preoccupation Scale - testversion (SPSt) Week 0, Week 8 Change in preoccupation of symptoms from baseline to week 8
Body Sensations Questionnaire (BSQ) Week 0, Week 8 Change in fear of bodily sensations in agoraphobics
WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) Week 0, Week 8 Change in functioning and disability
Credibility/Expectancy Questionnaire (CEQ) Week 2 Measuring treatment expectancy and rationale credibility for use in clinical outcome studies
Brunnsviken Quality of Life Questionnaire (BBQ) Week 0, Week 8 Change in self-perceived quality of life from baseline to week 8
Agoraphobic Cognitions Questionnaire (ACQ) Week 0, Week 8 Change in fear of fear in agoraphobics
Generalised Anxiety Disorder Assessment (GAD-7) Week 0, Week 8 Screening tool and severity measure for generalised anxiety disorder
The Cardiac Anxiety Questionnaire (CAQ) Week 0, Week 8 Change in heart-focused anxiety from baseline to week 8
Adverse events scale Week 8 To assess any adverse events caused by the treatment
Trial Locations
- Locations (1)
Karolinska Institutet
🇸🇪Stockholm, Sweden
Karolinska Institutet🇸🇪Stockholm, Sweden